Linden Thomas Advisory Services’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.23M Buy
25,106
+582
+2% +$68.1K 0.26% 108
2026
Q1
$2.95M Buy
24,524
+12,141
+98% +$1.4M 0.28% 103
2025
Q4
$1.3M Buy
12,383
+222
+2% +$20.8K 0.13% 245
2025
Q3
$1.02M Buy
12,161
+185
+2% +$15.2K 0.1% 289
2025
Q2
$948K Buy
11,976
+317
+3% +$25.2K 0.1% 293
2025
Q1
$1.05M Buy
11,659
+726
+7% +$67.8K 0.14% 266
2024
Q4
$1.09M Buy
10,933
+696
+7% +$71.8K 0.14% 265
2024
Q3
$1.16M Buy
10,237
+438
+4% +$52K 0.16% 249
2024
Q2
$1.21M Buy
9,799
+737
+8% +$94.9K 0.19% 228
2024
Q1
$1.2M Buy
9,062
+605
+7% +$74.6K 0.19% 225
2023
Q4
$922K Sell
8,457
-262
-3% -$27.2K 0.17% 246
2023
Q3
$898K Buy
+8,719
New +$940K 0.2% 216

Other funds holding MRK

Linden Thomas Advisory Services's MRK Position: Q2 2026 in Review

Linden Thomas Advisory Services increased its Merck (MRK) stake by 2.4% in Q2 2026, buying an estimated $68.1K and bringing the position to 25,106 shares worth $3.23M. The position accounts for 0.26% of the portfolio, ranked #108.

Linden Thomas Advisory Services first reported a position in MRK in Q3 2023 and has held it in 12 quarters since. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Linden Thomas Advisory Services held 25,106 shares of Merck worth $3.23M as of Q2 2026.
  • Linden Thomas Advisory Services bought 582 Merck shares in Q2 2026, an estimated $68.1K.
  • Merck made up 0.26% of Linden Thomas Advisory Services's portfolio in Q2 2026, its #108 holding.
  • Linden Thomas Advisory Services first reported a position in Merck in Q3 2023 and has held it in 12 quarters since.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.